Literature DB >> 16569324

Wide range of chromosome abnormalities in the embryos of young egg donors.

S Munné1, J Ary, C Zouves, T Escudero, F Barnes, C Cinioglu, B Ary, J Cohen.   

Abstract

Embryo chromosome studies show high rates of abnormalities, above 50%, but most embryos studied were from patients aged 35 and older. The objectives of this study were firstly, to evaluate the rate of chromosome abnormalities in embryos from young egg donors, and secondly, to compare the range of chromosome abnormality rates between donors and non-egg donor cycles, both undergoing preimplantation genetic diagnosis (PGD) for infertility using fluorescence in-situ hybridization analysis with probes for chromosomes X, Y, 13, 15, 16, 18, 21, and 22. On average, only 43% of the embryos were chromosomally normal, while the comparison group had euploidy rates between 34 (age group 18-34) (P < 0.001) and 21% (age group 40-45) (P < 0.001). There was considerable variation between donor cycles, with almost one-third having less than 30% normal embryos. Also, within donors and recipients repeating several IVF cycles with PGD, only 29-56% of the second PGD cycles had similar rates of normal embryos to the first cycle, while in the comparison group it was 64%. The results can explain why some egg donors are successful whereas others are not, and may also show that a policy of PGD for first time egg donors is appropriate and indicated.

Entities:  

Mesh:

Year:  2006        PMID: 16569324     DOI: 10.1016/s1472-6483(10)61007-3

Source DB:  PubMed          Journal:  Reprod Biomed Online        ISSN: 1472-6483            Impact factor:   3.828


  21 in total

1.  The effect of age on in vitro fertilization outcome: is too young possible?

Authors:  Zohreh Nazemian; Navid Esfandiari; Murid Javed; Robert F Casper
Journal:  J Assist Reprod Genet       Date:  2010-11-02       Impact factor: 3.412

Review 2.  PGS-FISH in reproductive medicine and perspective directions for improvement: a systematic review.

Authors:  Sandra Zamora; Ana Clavero; M Carmen Gonzalvo; Juan de Dios Luna Del Castillo; Jose Antonio Roldán-Nofuentes; Juan Mozas; Jose Antonio Castilla
Journal:  J Assist Reprod Genet       Date:  2011-06-29       Impact factor: 3.412

Review 3.  Preimplantation genetic screening: does it help or hinder IVF treatment and what is the role of the embryo?

Authors:  Kim Dao Ly; Ashok Agarwal; Zsolt Peter Nagy
Journal:  J Assist Reprod Genet       Date:  2011-07-09       Impact factor: 3.412

4.  Trends, fads and ART!

Authors:  Brian Dale; Yves Menezo; Gianfranco Coppola
Journal:  J Assist Reprod Genet       Date:  2015-01-06       Impact factor: 3.412

5.  Preimplantation genetic testing and chances of a healthy live birth amongst recipients of fresh donor oocytes in the United States.

Authors:  Cassandra Roeca; Rachel Johnson; Nichole Carlson; Alex J Polotsky
Journal:  J Assist Reprod Genet       Date:  2020-07-02       Impact factor: 3.412

6.  Early embryo mortality in natural human reproduction: What the data say.

Authors:  Gavin E Jarvis
Journal:  F1000Res       Date:  2016-11-25

7.  Is younger better? Donor age less than 25 does not predict more favorable outcomes after in vitro fertilization.

Authors:  Leigh A Humphries; Laura E Dodge; Erin B Kennedy; Kathryn C Humm; Michele R Hacker; Denny Sakkas
Journal:  J Assist Reprod Genet       Date:  2019-06-10       Impact factor: 3.412

8.  In vitro fertilization in women under 35: counseling should differ by age.

Authors:  K C Humm; L E Dodge; L H Wu; A S Penzias; B A Malizia; D Sakkas; M R Hacker
Journal:  J Assist Reprod Genet       Date:  2015-09-14       Impact factor: 3.412

9.  The cumulative dose of gonadotropins used for controlled ovarian stimulation does not influence the odds of embryonic aneuploidy in patients with normal ovarian response.

Authors:  Lucky Sekhon; Kathryn Shaia; Anthony Santistevan; Karen Hunter Cohn; Joseph A Lee; Piraye Yurttas Beim; Alan B Copperman
Journal:  J Assist Reprod Genet       Date:  2017-03-20       Impact factor: 3.412

10.  Moderate ovarian stimulation does not increase the incidence of human embryo chromosomal abnormalities in in vitro fertilization cycles.

Authors:  Elena Labarta; Ernesto Bosch; Pilar Alamá; Carmen Rubio; Lorena Rodrigo; Antonio Pellicer
Journal:  J Clin Endocrinol Metab       Date:  2012-08-03       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.